P2.01-014 ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients with NSCLC and ECOG PS 2
Autor: | Gajra, A., Karim, N. Abdel, Mulford, D., Matrana, M., Ali, H., Santos, E., Ong, T.J., Sanford, A., Amiri, K., Spigel, D. |
---|---|
Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2074-S2074 |
Databáze: | ScienceDirect |
Externí odkaz: |